GPD2 Polyclonal Antibody - E-AB-19535 Nucleic Acid Tranfection one with a high and

one with a high and the second with a low metastatic capacity

BS91283-100

Swiss-Prot: P07316

Immunogen: A synthesized peptide derived from human SCARB1

AA Sequence: AGCAGCCTGGGCGGTACCGATAAAGAACTGCGTCTGGTGGATGGTGAAAATAAATGCAGTGGTCGTGTGGAAGTGAAAGTTCAGGAAGAATGGGGCACCGTGTGTAATAATGGTTGGAGCATGGAAGCCGTTAGCGTGATCTGTAATCAGCTGGGCTGCCCGACCGCAATTAAAGCCCCGGGCTGGGCCAATAGTAGTGCAGGCAGTGGCCGTATCTGGATGGATCATGTTAGCTGCCGTGGCAATGAAAGCGCCCTGTGGGATTGTAAACATGATGGTTGGGGCAAACATAGTAATTGTACCCATCAGCAGGATGCCGGTGTTACCTGTAGTGATGGCAGTAATCTGGAAATGCGTCTGACCCGCGGTGGCAATATGTGCAGTGGCCGTATTGAAATTAAATTCCAGGGCCGCTGGGGCACCGTGTGTGATGATAACTTCAATATTGATCATGCAAGTGTTATCTGTCGTCAGCTGGAATGTGGTAGCGCCGTTAGCTTCAGTGGCAGTAGTAACTTCGGTGAAGGCAGTGGTCCGATCTGGTTCGATGATCTGATCTGTAATGGTAATGAAAGTGCCCTGTGGAATTGTAAACATCAGGGTTGGGGTAAACATAATTGTGATCATGCCGAAGATGCCGGTGTGATCTGTAGTAAAGGCGCAGATCTGAGTCTGCGTCTGGTTGATGGTGTGACCGAATGCAGTGGTCGCCTGGAAGTTCGCTTCCAGGGTGAATGGGGTACCATCTGTGATGATGGTTGGGATAGCTATGATGCAGCAGTTGCCTGTAAACAGCTGGGCTGTCCGACCGCAGTGACCGCCATTGGTCGCGTGAATGCAAGTAAAGGCTTCGGTCATATCTGGCTGGATAGCGTTAGCTGCCAGGGCCATGAACCGGCAATCTGGCAGTGCAAACATCATGAATGGGGCAAACACTATTGTAATCATAATGAAGATGCCGGCGTGACCTGTAGTGACGGTAGTGATCTGGAACTGCGTCTTCGCGGTGGTGGCAGTCGTTGTGCAGGTACCGTTGAAGTTGAAATTCAGCGTCTGCTGGGTAAAGTGTGTGATCGCGGCTGGGGTCTGAAAGAAGCAGATGTTGTGTGCCGCCAGCTGGGTTGTGGCAGCGCCCTGAAAACCAGTTATCAGGTGTATAGTAAAATCCAGGCAACCAATACCTGGCTGTTCCTGAGCAGTTGTAATGGTAACGAAACCAGTCTGTGGGATTGCAAAAATTGGCAGTGGGGTGGCCTGACCTGTGATCATTATGAAGAAGCCAAAATTACCTGTAGCGCACATCGCGAACCGCGCCTGGTTGGCGGCGATATTCCGTGCAGTGGCCGCGTTGAAGTTAAACATGGTGATACCTGGGGCAGTATCTGTGATAGCGACTTCAGTCTGGAAGCAGCCAGCGTTCTGTGTCGCGAACTGCAGTGTGGCACCGTTGTTAGTATTCTGGGCGGCGCACACTTCGGCGAAGGCAATGGTCAGATCTGGGCAGAAGAATTCCAGTGTGAAGGTCATGAAAGCCATCTGAGTCTGTGTCCGGTTGCACCGCGTCCGGAAGGCACCTGCAGCCATAGTCGCGATGTTGGTGTTGTGTGTAGCCGCTATACCGAAATTCGTCTGGTTAATGGCAAAACACCTTGCGAAGGTCGTGTTGAACTGAAAACCTTAGGTGCCTGGGGTAGCCTGTGCAATAGTCATTGGGATATTGAAGATGCCCATGTTCTGTGCCAGCAGCTGAAATGCGGTGTTGCACTGAGTACCCCGGGCGGCGCACGCTTCGGTAAAGGTAATGGCCAGATCTGGCGTCACATGTTCCATTGCACCGGCACCGAACAGCACATGGGCGATTGTCCGGTTACCGCCCTGGGTGCCAGCCTGTGTCCGAGCGAACAGGTGGCAAGCGTGATCTGTAGCGGCAATCAGAGTCAGACCCTGAGCAGCTGCAATAGTAGCAGCCTGGGTCCGACCCGTCCGACCATTCCGGAAGAAAGCGCCGTGGCCTGCATTGAAAGCGGTCAGCTGCGTCTGGTCAATGGTGGCGGTCGTTGTGCCGGTCGTGTGGAGATCTATCATGAAGGCAGTTGGGGTACCATCTGTGACGATAGTTGGGATCTGAGCGATGCCCATGTGGTGTGTCGTCAGTTAGGTTGCGGCGAAGCCATTAATGCAACCGGTAGCGCACACTTCGGTGAAGGTACCGGTCCGATCTGGCTGGACGAAATGAAATGCAATGGTAAAGAAAGCCGTATCTGGCAGTGTCATAGCCATGGTTGGGGCCAGCAGAATTGCCGCCATAAAGAAGATGCAGGTGTTATCTGTAGCGAATTCATGAGCCTGCGCCTGACCAGTGAAGCCAGTCGCGAAGCATGCGCCGGCCGTCTGGAAGTGTTCTATAATGGTGCCTGGGGCACCGTT

GPD2 Polyclonal Antibody - E-AB-19535 Nucleic Acid Tranfection one with a high andGPD2 Polyclonal Antibody Sizes: 60L, 120L, 200L Catalogue Numbers: E AB 19535 60, E AB 19535 120, E AB 19535 200 Citations, Manuals and MSDS Available upon request. Abbreviation: GPD2 Target Synonym: GDH2; Glycerol 3 phosphate dehydrogenase 2 (mitochondrial); Glycerol 3 phosphate dehydrogenase 2; Glycerol 3 phosphate dehydrogenase mitochondrial; Glycerol 3 phosphate dehydrogenase; GPD 2; GPD M; GPD M; gpd2; GPDH M; GPDH M; GPDM; GPDM; mGPDH;